Perspective Therapeutics CATX
NYSE CATX
$2.73 +0.12 (+4.39%)
As of: Sep 30, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Current Deferred Revenue (2024)

Updated

Perspective Therapeutics' Current Deferred Revenue was $1.4 million in Q4 2024, unchanged from the prior quarter.

Analysis

Perspective Therapeutics (CATX) Current Deferred Revenue (2024) Analysis & Trends

From Q1 2024 onward, Perspective Therapeutics has reported Current Deferred Revenue for 4 quarters.

  • Per Business Quant data, CATX's Current Deferred Revenue in the three quarters before Q4 2024 was $1.4 million (Q3 2024), $1.4 million (Q2 2024) and $1.4 million (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Perspective Therapeutics 298.91 Mn 298.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1.40 Mn
Sep 30, 2024 1.40 Mn
Jun 30, 2024 1.40 Mn
Mar 31, 2024 1.40 Mn
API Access

Perspective Therapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CATX&period=max&api_key=YOUR_API_KEY